ADC Therapeutics Appoints Former Genmab VP Dr Patrick van Berkel as Senior VP of R&D
ADC Therapeutics (ADCT) announced the appointment of former Genmab Vice President Dr Patrick van Berkel as Senior Vice President, Research & Development.
Dr van Berkel has more than twenty years’ experience in the biotech industry, and in particular in developing antibody based therapeutics. He served with Genmab for more than nine years in different divisions; his most recent position was as Vice President of Chemistry, Manufacturing and Control (CMC), Research & Development. Previously, he held senior positions, including Director of Technology for the Antibody Technology division, before moving across to CMC in 2008. Prior to Genmab, Dr van Berkel worked for both Crucell and Pharming Technologies. He is an author on at least nine antibody patents and has published over thirty peer-reviewed scientific papers during his career in the industry.
Other news from the department people
